638
Views
20
CrossRef citations to date
0
Altmetric
Review

Role of cardiac pacing in congenital complete heart block

, &
Pages 853-861 | Received 25 Apr 2017, Accepted 04 Sep 2017, Published online: 13 Sep 2017

References

  • Narula OS, Scherlag BJ, Javier RP, et al. Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms. Circulation. 1970;41:437–448.
  • White PD, Eustis RS, Kerr WJ. Arch. Pediatr Adolesc Med. 1921;22:299.
  • Yater WM. Congenital heart block. Am J Dis Child. 1929;38:112.
  • Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11:301–312.
  • Michaëlsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin. 1972;4:85–101.
  • Donofrio MT, Moon-Grady AJ, Hornerger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183–2242.
  • Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–1666.
  • Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. Autoimmune congenital heart block: complex and unusual situations. Lupus. 2016;25:116–128.
  • Capone C, Buyon JP, Friedman DM, et al. Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population. Cardiol Rev. 2011;20:72–76.
  • Lee LA, Weston WL. New findings in neonatal lupus syndrome. Am J Dis Child. 1984;138:233–236.
  • Llanos C, Friedman DM, Izmirly PM, et al. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus. Rheumatology. 2012;51:1086–1092.
  • Anderson RH, Ho SY. The disposition of the conduction tissues in congenitally malformed hearts with reference to their embryological development. J Perinat Med. 1991;19(Suppl 1):201–206.
  • Anderson RH, Wenick AC, Losekoot TG, et al. Congenitally complete heart block. Developmental aspects. Circulation. 1977;56:90–101.
  • Mori AD, Bruneau BG. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol. 2004;19:211–215.
  • Baruteau AE, Fouchard S, Behaghel A, et al. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study. Eur Heart J. 2012;33:622–629.
  • Baruteau AE, Behaghel A, Fouchard S, et al. Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atrioventricular block. Circulation. 2012;126:1469–1477.
  • Lev M, Silverman J, Fitzmaurice FM, et al. Lack of connection between the atria and the more peripheral conduction system in congenital atrioventricular block. Am J Cardiol. 1971;27:481–490.
  • Lev M, Cuadros H, Paul MH. Interruption of the atrioventricular bundle with congenital atrioventricular block. Circulation. 1971;43:703–710.
  • Lev M. The pathology of complete atrioventricular block. Prog Cardiovasc Dis. 1964;6:317–326.
  • Miranda-Carús ME, Askanase AD, Clancy RM, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol. 2000;165:5345–5351.
  • Xiao GQ, Hu K, Boutjdir M. Direct inhibition of expressed cardiac l- and t-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation. 2001;103:1599–1604.
  • Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, et al. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus. 2005;14:660–664.
  • Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation. 2002;105:843–848.
  • Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol. 2002;39:130–137.
  • Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med. 1994;120:544–551.
  • Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med. 1987;316:835–839.
  • Schmidt KG, Ulmer HE, Silverman NH, et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol. 1991;17:1360–1366.
  • Michaëlsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation. 1995;92:442–449.
  • Udink ten Cate FE, Breur JM, Cohen MI, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol. 2001;37:1129–1134.
  • Assad RS, Zielinsky P, Kalil R, et al. New lead for in utero pacing for fetal congenital heart block. J Thorac Cardiovasc Surg. 2003;126:300–302.
  • Vest AN, Zhou L, Huang X, et al. Design and testing of a transcutaneous RF recharging system for a fetal micropacemaker. IEEE Trans Biomed Circuits Syst. 2017;11:336–346.
  • Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5:934–955.
  • Takeuchi D, Tomizawa Y. Pacing device therapy in infants and children: a review. J Artif Organs. 2013;16:23–33.
  • Wilhelm BJ, Thone M, El-Scheich T, et al. Complications and risk assessment of 25 years in pediatric pacing. Ann Thorac Surg. 2015;100:147–153.
  • Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr. 2016;175:1235–1248.
  • Fortescue EB, Berul CI, Cecchin F, et al. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–159.
  • Kubus P, Materna O, Gebauer RA, et al. Permanent epicardial pacing in children: long-term results and factors modifying outcome. Europace. 2012;14:509–514.
  • Vos LM, Kammeraad JAE, Freund MW, et al. Long-term outcome of transvenous pacemaker implantation in infants: a retrospective cohort study. Europace. 2016;euw031.
  • Silvetti MS, Drago F, De Santis A, et al. Single-centre experience on endocardial and epicardial pacemaker system function in neonates and infants. Europace. 2007;9:426–431.
  • Robledo-Nolasco R, Ortiz-Avalos M, Rodriguez-Diez G, et al. Transvenous pacing in children weighing less than 10 kilograms. Pacing Clin Electrophysiol. 2009;Suppl 1:S177–S181.
  • Kammeraad JAE, Rosenthal E, Bostock J, et al. Endocardial pacemaker implantation in infants weighing <= 10 kilograms. Pacing Clin Electrophysiol. 2004;27:1466–1474.
  • Konta L, Chubb MH, Bostock J, et al. Twenty-seven years experience with transvenous pacemaker implantation in children weighing <10 kg. Circ Arrhythmia Electrophysiol. 2016;9(2):e003422.
  • Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006;113:2391–2397.
  • Brunner MP, Cronin EM, Duarte VE, et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm. 2014;11:799–805.
  • El-Chami MF, Merchant FM, Waheed A, et al. Predictors and outcomes of lead extraction requiring a bailout femoral approach: data from 2 high-volume centers. Heart Rhythm. 2017;14:548–552.
  • Friedman RA, Van Zandt H, Collins E, et al. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol. 1996;19:778–783.
  • Zartner PA, Wiebe W, Toussaint-Goetz N, et al. Lead removal in young patients in view of lifelong pacing. Europace. 2010;12:714–718.
  • Escano FB, Berroya RB, Gianfrancesco H, et al. Intrapleural pacemaker generator in children. J Thorac Cardiovasc Surg. 1971;62:454–456.
  • Agarwal R, Krishnan GS, Abraham S, et al. Extrapleural intrathoracic implantation of permanent pacemaker in the pediatric age group. Ann Thorac Surg. 2007;83:1549–1552.
  • Janousek J, van Geldorp IE, Krupickova S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circulation. 2013;127:613–623.
  • Silvetti MS, Di Carlo D, Ammirati A, et al. Left ventricular pacing in neonates and infants with isolated congenital complete or advanced atrioventricular block: short- and medium-term outcome. Europace. 2015;17:603–610.
  • Carreras EM, Duncan WJ, Djurdjev O, et al. Cardiac strangulation following epicardial pacemaker implantation: a rare pediatric complication. J Thorac Cardiovasc Surg. 2015;149:522–527.
  • Alhuzaimi A, Roy N, Duncan WJ. Cardiac strangulation from epicardial pacemaker: early recognition and prevention. Cardiol Young. 2011;21:471–473.
  • Eyskens B, Mertens L, Moerman P, et al. Cardiac strangulation, a rare complication of epicardial pacemaker leads during growth. Heart. 1997;77:288–289.
  • Lamas GA, Orav EJ, Strambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker selection in the elderly investigators. N Engl J Med. 1998;338:1097–1104.
  • Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian trial of physiologic pacing investigators. N Engl J Med. 2000;342:1385–1391.
  • Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005;353:145–155.
  • Hoijer C, Brandt J, Willenheimer R, et al. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation. Eur Heart J. 2002;23:490–497.
  • Naegeli B, Kurz DJ, Koller D, et al. Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing. Europace. 2007;9:194–199.
  • Ouali S, Neffeti E, Ghoul K, et al. DDD versus VVIR pacing in patients, ages 70 and over, with complete heart block. Pacing Clin Electrophysiol. 2009;33:583–589.
  • Horenstein MS, Karpawich PP, Tantengco MVT. Single versus dual chamber pacing in the young: noninvasive comparative evaluation of cardiac function. Pacing Clin Electrophysiol. 2003;26:1208–1211.
  • Hauser J, Michel-Behnke I, Zervan K, et al. Noninvasive measurement of atrial contribution to the cardiac output in children and adolescents with congenital complete atrioventricular block treated with dual-chamber pacemakers. Am J Cardiol. 2011;107:92–95.
  • Ragonese P, Guccione P, Drago F, et al. Efficacy and safety of ventricular rate responsive pacing in children with complete atrioventricular block. Pacing Clin Electrophysiol. 1994;17:603–610.
  • Celiker A, Ceviz N, Alehan D, et al. Comparison of normal sinus rhythm and pacing rate in children with minute ventilation single chamber rate adaptive permanent pacemakers. Pacing Clin Electrophysiol. 1998;21:2100–2104.
  • Karpawich PP, Perry BL, Farooki ZQ, et al. Pacing in children and young adults with nonsurgical atrioventricular block: comparison of single-rate ventricular and dual-chamber modes. Am Heart J. 1987;113:316–321.
  • Thambo J-B, Bordachar P, Garrigue S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation. 2004;110:3766–3772.
  • Moak JP, Hasbani K, Ramwell C, et al. Dilated cardiomyopathy following right ventricular pacing for AV block in young patients: resolution after upgrading to biventricular pacing systems. J Cardiovasc Electrophysiol. 2006;17:1068–1071.
  • Sagar S, Shen WK, Asirvathaim SJ, et al. Effect of long-term right ventricular pacing in young adults with structurally normal heart. Circulation. 2010;121:1698–1705.
  • Giudici MC, Thornburg GA, Buck DL, et al. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol. 1997;79:209–212.
  • Victor F, Leclercg C, Mabo P, et al. Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol. 1999;33:311–316.
  • Schwaab B, Frohlig G, Alexander C, et al. Influence of right ventricular stimulation site on left ventricular function in atrial synchronous ventricular pacing. J Am Coll Cardiol. 1999;33:317–323.
  • Tse HF, Yu C, Wong KK, et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol. 2002;40:1451–1458.
  • Stambler BS, Ellenbogen K, Zhang X, et al. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14:1180–1186.
  • Buckingham TA, Candinas R, Attenhofer C, et al. Systolic and diastolic function with alternate and combined site pacing in the right ventricle. Pacing Clin Electrophysiol. 1998;21:1077–1084.
  • Shimony A, Eisenberg MJ, Filion KB, et al. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace. 2012;14:81–91.
  • Kaye GC, Linker NJ, Marwick TH, et al. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the protect-pace study. Eur Heart J. 2015;36:856–862.
  • Karpawich PP, Singh H, Zelin K. Optimizing paced ventricular function in patients with and without repaired congenital heart disease by contractility-guided lead implant. Pacing Clin Electrophysiol. 2015;38:54–62.
  • Deshmukh P, Casavant DA, Romanyshyn M, et al. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation. 2000;101:869–877.
  • Dandamudi G, Vijayaraman P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016;13:1362–1366.
  • Kronborg MB, Mortensen PT, Poulsen SH, et al. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014;16:1189–1196.
  • Sharma PS, Huizar J, Ellenbogen KA, et al. Recruitment of bundle branches with permanent His bundle pacing in a patient with advanced conduction system disease: what is the mechanism? Heart Rhythm. 2016;13:623–625.
  • Sharma PS, Dandamudi G, Naperkowski A, et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015;12:305–312.
  • Zanon F, Svetlich C, Occhetta E, et al. Safety and performance of a system specifically designed for selective site pacing. Pacing Clin Electrophysiol. 2011;34:339–347.
  • Linde C, Braunschweig F, Gadler F, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118.
  • Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.
  • Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–1338.
  • Cleland J, Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. J Am Coll Cardiol. 2008;52:438–445.
  • Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009;54:1837–1846.
  • Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients. J Am Coll Cardiol. 2005;46:2277–2283.
  • van Beek E, Backx A, Singh S. Cardiac resynchronization as therapy for congestive cardiac failure in children dependent on chronic cardiac pacing. Cardiol Young. 2006;16:187–189.
  • Janousek J. Cardiac resynchronisation in congenital heart disease. Heart. 2009;95:940–947.
  • Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58–65.
  • Curtis AB, Worley SJ, Chung ES, et al. Improvement in clinical outcomes with biventricular versus right ventricular pacing. J Am Coll Cardiol. 2016;67:2148–2157.
  • Funck RC, Mueller HH, Lunati M, et al. Characteristics of a large sample of candidates for permanent ventricular pacing included in the biventricular pacing for atrio-ventricular block to prevent cardiac desynchronization study (BioPace). Europace. 2014;16:354–362.
  • Czosek RJ, Meganathan K, Anderson JB, et al. Cardiac rhythm devices in the pediatric population: utilization and complications. Heart Rhythm. 2012;9:199–208.
  • Welisch E, Cherlet E, Crespo-Martinez E, et al. A single institution experience with pacemaker implantation in a pediatric population over 25 years. Pacing Clin Electrophysiol. 2010;33:1112–1118.
  • Chaouki AS, Spar DS, Khoury PR, et al. Risk factors for complications in the implantation of epicardial pacemakers in neonates and infants. Heart Rhythm. 2017;14:206–210.
  • Lotfy W, Hegazy R, AbdElAziz O, et al. Permanent cardiac pacing in pediatric patients. Pediatr Cardiol. 2013;34:273–280.
  • Zartner P, Handke R, Photiadis J, et al. Performance of an autonomous telemonitoring system in children and young adults with congenital heart diseases. Pacing Clin Electrophysiol. 2008;31:1291–1299.
  • Fauchier L, Sadoul N, Kouakam C, et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2005;28:S255–S259.
  • Varma N, Piccini JP, Snell J, et al. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. 2015;65:2601–2610.
  • Dechert BE, Serwer GA, Bradley DJ, et al. Cardiac implantable electronic device remote monitoring surveillance in pediatric and congenital heart disease: utility relative to frequency. Heart Rhythm. 2015;12:117–122.
  • Leoni L, Padalino M, Biffanti R, et al. Pacemaker remote monitoring in the pediatric population: is it a real solution? Pacing Clin Electrophysiol. 2015;38:565–571.
  • Silvetti MS, Saputo FA, Palmieri R, et al. Results of remote follow-up and monitoring in young patients with cardiac implantable electronic devices. Cardiol Young. 2016;26:53–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.